Blog
4 key reasons for genetic testing in clinical trials
Learn key reasons why genetic testing may be used in a clinical trial—and what you should know as a prospective participant.
Blog
Learn key reasons why genetic testing may be used in a clinical trial—and what you should know as a prospective participant.
When screening for a clinical trial, you may learn that genetic testing is part of the study. This type of testing is included in some trials and, depending on the trial, may involve providing a biological sample, such as blood or saliva.
If you have never encountered genetic testing in clinical research before, you may wonder what researchers are looking for, and what your genes have to do with the treatment being studied.
Genetic testing may serve different purposes depending on the trial. Researchers may use genetic information to better understand differences among participants, study how people respond to medications, identify participants who meet specific study criteria, or answer questions about the safety and effectiveness of an investigational treatment.
Keep reading to learn more about four key reasons why genetic testing may be used in a clinical trial—and what you should know as a prospective participant.
Reason #1:
People do not always respond to medications in the same way. One factor that can contribute to these differences is genetic variation.
The field of pharmacogenomics studies how a person’s genes may affect their response to medications. Researchers can use this information to explore why a medication may work differently among individuals or why some people may experience different effects from the same treatment.
According to the National Institutes of Health (NIH), pharmacogenomics research examines the relationship between DNA patterns and medication response. The goal is to better understand individual differences rather than assuming that the same treatment or dose will affect everyone in exactly the same way.
Genetics is only one part of the picture. Age, other medications, health conditions, and many other factors may also influence how someone responds to a drug. The U.S. Food and Drug Administration (FDA) similarly notes that genetic makeup is one of multiple factors that may affect drug concentrations and response.
For clinical researchers, studying these differences can provide valuable information about an investigational treatment and the people who may respond to it.
Reason #2:
Genetic differences can sometimes affect how quickly or slowly the body processes certain medications.
For example, CYP2D6 is a gene associated with an enzyme involved in metabolizing several medications.
Variations associated with CYP2D6 may affect drug concentrations for some medications. The FDA includes CYP2D6 among the genes for which genetic variations have documented associations with the way certain drugs are processed in the body.
In clinical research, information like this may help researchers study:
The FDA notes that pharmacogenomic information can play a role in understanding drug exposure, differences in clinical response, adverse-event risk, dosing, and clinical trial design.
That doesn’t mean that every genetic variation has a known effect on every medication. Researchers may conduct genetic testing precisely because they are trying to learn more about those relationships.
Reason #3:
Every clinical trial has eligibility criteria, which identify who may or may not participate. These requirements are based on the specific question researchers are trying to answer.
In some studies, a particular genetic characteristic or biomarker may be one of those criteria.
For example, researchers studying a targeted treatment may want to evaluate how it works in people who share a particular biological characteristic. Genetic testing can help determine whether a prospective participant has the characteristics being studied.
This approach is associated with precision medicine, which uses information about individual differences to help researchers study more targeted approaches to treatment. The NIH describes a major goal of precision medicine as moving beyond a one-size-fits-all approach and toward understanding which treatments and doses may be appropriate for patients.
In some situations, pharmacogenomic testing can provide information about how a person’s genes may affect the way their body responds to certain medications. Healthcare providers may consider that information alongside other factors when making treatment decisions. Clinical researchers can study similar relationships to learn more about which treatments may be appropriate for different groups of people.
If genetic testing shows that someone does not meet a study’s eligibility requirements, that result does not necessarily mean there is something wrong with that person or their health. It may simply mean that the individual does not have the specific characteristic required to answer that study’s research question.
Reason #4:
Ultimately, clinical trials are designed to answer scientific questions. Genetic information can sometimes provide researchers with another way to understand the results they observe.
FDA guidance on pharmacogenomics explains that researchers may examine how differences in DNA sequences relate to a drug’s pharmacokinetics (how the body absorbs, distributes, metabolizes, and eliminates a drug), pharmacodynamics (how a drug affects the body), effectiveness, or safety.
For example, researchers may investigate whether a particular genetic variation is associated with differences in how participants respond to an investigational treatment. Over time, research like this can contribute to a broader understanding of how treatments affect different people.
Importantly, genetic testing does not automatically mean researchers can predict exactly how a particular treatment will affect an individual participant. Genetic information is one source of information among many others that researchers may consider.

It is reasonable to have questions about genetic testing, particularly about what will happen to your sample and information.
Before joining a clinical trial, the Trialmed study team will provide information about the study and what participation involves during the informed consent process. If genetic testing is included, you may ask the research team questions such as:
The answers can vary depending on the trial. Asking questions can help you understand exactly what you’re agreeing to before deciding whether to participate.
Trialmed values participant privacy and understands that you may have questions or concerns about how genetic samples and information are collected, used, stored, or shared. If genetic testing is part of a study you are considering, the study team can discuss the study’s privacy practices with you before you decide whether to participate.
No. Genetic testing is used only when it is relevant to the study’s design or research questions. Many clinical trials do not include genetic testing.
Not necessarily. Genetic testing may be used for several research purposes, including studying medication metabolism or treatment response. The reason for testing should be explained as part of the study information and informed consent process.
Not always. Whether individual results are returned to participants depends on the study and the type of testing being performed. Ask the research team whether results will be provided and what those results may or may not tell you.
Not necessarily. Some genetic variations are associated with differences in medication metabolism, response, or risk of adverse effects, but genetics is only one factor that can influence how someone responds to treatment.
How genetic samples and data are collected, stored, used, and shared depends on the study. Prospective participants should receive information about these practices during the consent process and can ask the study team for additional details before agreeing to participate. Trialmed values participant privacy, and you are encouraged to ask the study team any questions or raise any concerns you have about your genetic information before deciding whether to participate.
Genetic testing is one of many tools that researchers may use to better understand how investigational treatments affect different people. When genetic testing is part of a clinical trial, understanding why it is being performed, and how your information will be used—can help you make a more informed decision about participation.
If you are considering a clinical trial that includes genetic testing, ask the study team to explain what is being tested, why it matters to the research, and what the results may mean for you.
Trialmed connects prospective participants with clinical research opportunities and provides information to help people learn more about studies that may be available to them.
Ready to learn more about clinical trials and register your interest in participating?